Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
Wave of AI Bills to Continue Next Year As of early September, more than 30 states had passed artificial intelligence-related bills or resolutions this year, according to the National Conference of State...
MI Addresses Multiple Healthcare Issues Gov. Gretchen Whitmer (D) signed over half a dozen bills dealing with healthcare and family support. The measures include SB 790 and SB 791 , allowing home help...
In recent years, the boardroom has become a new front in the culture wars alongside a cacophony of three-letter acronyms. DEI, ESG and CSR. These buzzwords—short for diversity, equity and inclusion;...
Statehouse Shift Ahead for Earned Wage Access? In recent years earned wage access apps, which allow workers to obtain access to their earnings before they receive their paychecks, have exploded in popularity...
SD to Consider App- and Device-Based Age Verification Legislation in 2025 The South Dakota Legislature’s Study Committee on Artificial Intelligence and Regulation of Internet Access by Minors voted...
The U.S. Supreme Court will hear oral arguments in a case that could limit access to the abortion drug mifepristone on March 26. The FDA initially approved the drug for terminating pregnancies through seven weeks gestation in 2000 and extended that period to 10 weeks in 2016.
U.S. District Judge Matthew Joseph Kacsmaryk stayed FDA approval of the drug last April, but that decision was put on hold by the Supreme Court pending appeal. A three-judge panel of the 5th Circuit Court of Appeals ruled in August the drug could remain available under the prescription and dosage guidelines in effect prior to 2016, but that decision is on hold pending the ruling of the Supreme Court. (STATELINE)
A bill introduced in Arizona (SB 1511) would require doctors and health care institutions that provide gender-affirming care to also provide or pay for gender detransition procedures. The measure would also require insurers that cover gender-affirming care to cover detransition care. (NEWS FROM THE STATES, LEXISNEXIS STATE NET)
The governing board of the North Carolina State Health Plan voted last week to stop covering medications for weight loss, like the wildly popular drug Wegovy. The state spent $100 million on such drugs last year, 10% of the total amount it spent on prescription drugs. The state will continue to pay for versions of the drugs used to treat diabetes. (NEW YORK TIMES)
Legislation under consideration in Florida (SB 932/HB 773) would prohibit insurers from charging out-of-pocket costs for medically necessary diagnostic and supplemental breast exams. Over 22,000 Floridians were diagnosed with breast cancer last year, more than 3,000 of whom died from the disease, according to the Susan G. Komen organization, which attributed those figures in part to “exorbitant out-of-pocket costs associated with essential breast imaging procedures.” Close to a dozen states, including Georgia and Tennessee, have already passed measures similar to SB 932/HB 773. (FLORIDA POLITICS, SUSAN G KOMEN, LEXISNEXIS STATE NET)
—Compiled by SNCJ Managing Editor KOREY CLARK
Visit our webpage to connect with a LexisNexis® State Net® representative and learn how the State Net legislative and regulatory tracking service can help you identify, track, analyze and report on relevant legislative and regulatory developments.